Competitive Intelligence Tool

The Competitive Intelligence tool allows you to customize your close players with simple filters and data algorithms.

REQUEST DEMO

Competitive Intelligence Tool

The Competitive Intelligence tool enables you to detailed overview and display information such as company financials, key stats by drugs, trials, facilities, patents and deals for up to 20 companies at a time.

Keep up to date with all the latest company news and developments with save search and alerts.
Benchmark your company against close players in your research or market.
Allows you to customize competitors by molecule nature, geography, indication, drug target, company type, employee size and drug count.

Benefits for Healthcare Players:

Start-up and Contract Research & Manufacturing Companies:
Monthly newsletter with drug developments and contacts keep them up-to-date with material events and business leads.
Market size projections help you to get the business scope for raising investment.
Search for planned trials with CROs as collaborator within your sales territory.
Biopharma Companies:
Informed with competitor events and execute corporate planning by keeping a track on future drug and clinical trials milestones expected from your competitors.
Customize your key events tracking based on companies in the same technology or disease or target.
Generic Drugs and API manufacturer:
Helps you to plan drug portfolio management or strategy based on key pipeline class of drugs (future market share) and disease market by country.
Support you with planned trials by disease, sponsors/collaborators.
API, & Intermediates Manufactures:
Key pipeline class of drugs (future market share); disease market by key countries.
Generics by active ingredient in US, EU, & Japan, and Patent expiry for key pipeline and marketed drugs.
Financial Firms:
Keep track on early stage biotech companies and proactively evaluate companies based on future events and clinical trial success rates.
Set alerts for material events at companies within your portfolio or competing companies that may affect the valuation of your portfolio companies.